Gabapentin Capsule
Product Images NDC 25000-103

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 25000-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marksans Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gaba100mg 1000s Bottle

Gaba100mg 1000s Bottle
Gabapentin Capsules, USP with NDC-25000-103-14 are a medication containing 100 mg gabapentin per capsule, distributed in a bottle of 1000 capsules manufactured by Marksans Pharma Ltd. The medication guide should be provided to each patient. The full dosage and prescribing information are available in the package insert. The capsules must be stored between 20° to 25°C (68° to 77°F). The manufacturer is Time-Cap Labs, Inc. located in Farmingdale, NY, and the manufacturing site is in Verna, Goa, India. The product is for sale in the US and the manufacturing license number is GO/DRUGS/515.*
FDA Label Image

Gaba100mg-30s-bott (Gaba100mg 30s Bottle)

Gaba100mg-30s-bott (Gaba100mg 30s Bottle)
This appears to be product packaging information for Gabapentin Capsules, USP 100mg, manufactured by Marksans Pharma Ltd. It includes dosage and use information, storage instructions, and manufacturing information. The product is for Rx-only use and should be dispensed with the medication guide provided separately to each patient. Size specifications for the packaging are also provided.*
FDA Label Image

Gaba100mg-500s-bott (Gaba100mg 500s Bottle)

Gaba100mg-500s-bott (Gaba100mg 500s Bottle)
This is a description of medication packaging containing gabapentin capsules, USP 100mg. The size of the container is 140.00(L) x 80.00(H) mm, and it contains 500 capsules. The dosage and use information is provided on a package insert, and the medication should be stored at temperatures between 15 to 30°C (59° to 86°F). It also includes manufacturing information for the medication and the company Time-Cap Labs, Inc. There is a lot number provided for tracking purposes.*
FDA Label Image

Gaba300mg 1000s Bottle

Gaba300mg 1000s Bottle
This is a container of 1000 capsules of Gabapentin, USP, with each capsule containing 300 mg of the medication. The capsules are manufactured by Marksans Pharma Ltd. and distributed by Time-Cap Labs, Inc. The medication guide is provided separately by the pharmacist for each patient. The full prescribing information can be found in the package insert. The capsules should be stored at controlled room temperature and dispensed in a well-closed container as defined in the USP. The manufacturing license number is GO/DRUGS/515.*
FDA Label Image

Gaba300mg-30s-bott (Gaba300mg 30s Bottle)

Gaba300mg-30s-bott (Gaba300mg 30s Bottle)
This is information about Gabapentin Capsules, USP with a dosage of 300 mg. The size of each capsule is 90.00(L) X 35.00(H) mm. It contains details about the manufacturer and how to store the capsules. The pharmacist is advised to dispense the medication, and a patient guide is given separately. The label is in Pantone 355 C, Pantone 273 C, Pantone 300 C, and black. Since there is no clear description, this text can be classified as not-available.*
FDA Label Image

Gaba300mg-500s-bott (Gaba300mg 500s Bottle)

Gaba300mg-500s-bott (Gaba300mg 500s Bottle)
Gabapentin Capsules is a pharmaceutical product manufactured by Marksans Pharma Ltd. Each capsule contains 300mg of Gabapentin, USP. The product comes in a bottle dose of 500 capsules, with the size measuring 140.00(L) X 80.00(H) mm. The product is for Rx only, and pharmacists are required to dispense the medication guide separately to each patient. The drugs should be stored at a temperature of 20° to 25°C, with excursions permitted to 15° to 30°C. The product should be dispensed in a well-closed container as defined in the USP. Full prescribing information can be found in the package insert. The product was manufactured for Time-Cap Labs, Inc. and has been licensed by the GO/Drugs/515 by the company that manufactures it, Marksans Pharma Ltd. The lot and expiry details are not available in the text.*
FDA Label Image

Gaba400mg 1000s Bottle

Gaba400mg 1000s Bottle
Gabapentin Capsules, USP 400mg by Marksans Pharma Ltd. are supplied in a bottle of 1000 capsules. Each capsule contains Gabapentin, USP 400mg. The medication guide should be distributed to each patient. Please refer to the package insert for full prescribing information. The medication should be stored at 20°-25°C (68°-77°F) with excursions permitted to 15°-30°C (59°-86°F). The product must be stored in a well-closed container as defined by the USP. The manufacturer, Time-Cap Labs Inc., is located at 7 Michael Avenue, Farmingdale, NY 11735, USA.*
FDA Label Image

Gaba400mg-30s-bott (Gaba400mg 30s Bottle)

FDA Label Image

Gaba400mg-500s-bott (Gaba400mg 500s Bottle)

Gaba400mg-500s-bott (Gaba400mg 500s Bottle)
This is a description of Gabapentin capsules, USP which contain 400mg of Gabapentin, USP each. The package consists of 500 capsules manufactured by Marksans Pharma Ltd in India and distributed by Time-Cap Labs, Inc, NY. They should be stored at room temperature between 20-25°C and should be kept in a well-closed container. Each capsule should be dispensed with a medication guide for the patient. Further information and dosage directions can be found in the package insert, and the lot number and expiration date are also provided.*
FDA Label Image

Structure Of Gaba (Gabapentin Figure 01)

FDA Label Image

Figure-2 (Gabapentin Figure 02)

FDA Label Image

Figure-3 (Gabapentin Figure 03)

FDA Label Image

Figure-4 (Gabapentin Figure 04)

FDA Label Image

Figure-5 (Gabapentin Figure 05)

FDA Label Image

Gabapentin Figure 06

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.